EMT-related long non-coding RNA in hepatocellular carcinoma: A study with TCGA database

被引:31
作者
Zhang, Zonglin [1 ]
Wang, Surong [2 ]
Liu, Wenqi [1 ]
机构
[1] Linyi Peoples Hosp, Dept Pharm, 27 Jiefang Rd East Sect, Linyi 276400, Shandong, Peoples R China
[2] Linyi Peoples Hosp, Dept Obstet & Gynecol, Linyi 276900, Shandong, Peoples R China
关键词
Long non-coding RNA; Epithelial-to-mesenchymal transition; Hepatocellular carcinoma; MEG3; MIAT; WDFY3-AS2; EPITHELIAL-MESENCHYMAL TRANSITION; LINC00472; PROGRESSION; METASTASIS; EXPRESSION; LNCRNA; CELLS; MIAT;
D O I
10.1016/j.bbrc.2018.07.075
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulating evidence suggest that dysregulated expression of long non-coding RNA (IncRNA) plays a critical role in human tumorigenesis. However, little is known about the IncRNA implicated in the epithelial-to-mesenchymal transition (EMT) process. In this study, we performed data mining in The Cancer Genome Atlas (TCGA) hepatocellular carcinoma (HCC) data set and identified the a spectrum of differentially expressed lncRNAs implicated the EMT process of HCC, and functionally validated their roles in LM3 cells. Especially, IncRNA WDFY3-AS2-, LINC00472-, MIAT-, and MEG3-associated genes were significantly enriched in EMT-linked pathways. Loss-of-function study showed that genetic silencing of WDFY3-AS3, MIAT, and MEG3, but not LINC00472, resulted in reduced N-cadherin expression, cell migration, and cell invasion. Collectively, our results identify several lncRNAs that regulate the EMT process of HCC, which provides critical information for HCC tumorigenesis and potential therapeutic targets. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:1530 / 1536
页数:7
相关论文
共 33 条
[1]   Long Noncoding RNAs: Cellular Address Codes in Development and Disease [J].
Batista, Pedro J. ;
Chang, Howard Y. .
CELL, 2013, 152 (06) :1298-1307
[2]   EMT in cancer [J].
Brabletz, Thomas ;
Kalluri, Raghu ;
Angela Nieto, M. ;
Weinberg, Robert A. .
NATURE REVIEWS CANCER, 2018, 18 (02) :128-+
[3]   LncSox4 promotes the self-renewal of liver tumour-initiating cells through Stat3-mediated Sox4 expression [J].
Chen, Zhen-zhen ;
Huang, Lan ;
Wu, Ya-hong ;
Zhai, Wen-jie ;
Zhu, Ping-ping ;
Gao, Yan-feng .
NATURE COMMUNICATIONS, 2016, 7
[4]   Long Noncoding RNA HULC Modulates Abnormal Lipid Metabolism in Hepatoma Cells through an miR-9-Mediated RXRA Signaling Pathway [J].
Cui, Ming ;
Xiao, Zelin ;
Wang, Yue ;
Zheng, Minying ;
Song, Tianqiang ;
Cai, Xiaoli ;
Sun, Baodi ;
Ye, Lihong ;
Zhang, Xiaodong .
CANCER RESEARCH, 2015, 75 (05) :846-857
[5]   Epithelial-mesenchymal transition and inflammation at the site of the primary tumor [J].
Dominguez, Charli ;
David, Justin M. ;
Palena, Claudia .
SEMINARS IN CANCER BIOLOGY, 2017, 47 :177-184
[6]   Long non-coding RNAs: new players in cell differentiation and development [J].
Fatica, Alessandro ;
Bozzoni, Irene .
NATURE REVIEWS GENETICS, 2014, 15 (01) :7-21
[7]   Hepatocellular carcinoma [J].
Forner, Alejandro ;
Reig, Maria ;
Bruix, Jordi .
LANCET, 2018, 391 (10127) :1301-1314
[8]   Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer [J].
Fu, Yuanyuan ;
Biglia, Nicoletta ;
Wang, Zhanwei ;
Shen, Yi ;
Risch, Harvey A. ;
Lu, Lingeng ;
Canuto, Emilie Marion ;
Jia, Wei ;
Katsaros, Dionyssios ;
Yu, Herbert .
GYNECOLOGIC ONCOLOGY, 2016, 143 (03) :642-649
[9]   Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis [J].
Gupta, Rajnish A. ;
Shah, Nilay ;
Wang, Kevin C. ;
Kim, Jeewon ;
Horlings, Hugo M. ;
Wong, David J. ;
Tsai, Miao-Chih ;
Hung, Tiffany ;
Argani, Pedram ;
Rinn, John L. ;
Wang, Yulei ;
Brzoska, Pius ;
Kong, Benjamin ;
Li, Rui ;
West, Robert B. ;
van de Vijver, Marc J. ;
Sukumar, Saraswati ;
Chang, Howard Y. .
NATURE, 2010, 464 (7291) :1071-U148
[10]   AASLD guidelines for the treatment of hepatocellular carcinoma [J].
Heimbach, Julie K. ;
Kulik, Laura M. ;
Finn, Richard S. ;
Sirlin, Claude B. ;
Abecassis, Michael M. ;
Roberts, Lewis R. ;
Zhu, Andrew X. ;
Murad, M. Hassan ;
Marrero, Jorge A. .
HEPATOLOGY, 2018, 67 (01) :358-380